Human Participant Research Restart Advisory Committee

This committee has been meeting regularly to advise on plans to restart human participant research as the University plans a Phase 1 reopening. The committee includes representatives from the School of Medicine, School of Nursing, Bloomberg School of Public Health, and Homewood.

 

Role of Committee
  • Advise the Vice Dean for Clinical Investigation on the overall phased approach for reopening research with in-person interaction.
  • Identify options for a safe restart for human participant research activity including processes for review of study protocols.
  • Identify and coordinate guidance for staff training and personal protective equipment for clinical research teams.

 

Committee Members
Gail Daumit, MD, MHS, FACP (chair)Janet Mighty, MBA
Irina Burd, MD, PhD
Ellen Mowry, MD
Mike Carducci MD, FACP
Geetanjali Chander, MD MPH
Bob Wise, MDTodd Brown, MD, PhDDan Ford, MD, MPH
Neil Goldenberg, MD PhDJanet Heussner
Suzanne Jan De Beur, MD
Corinne Keet, MD, MD, PhD
Gregory Kirk, MD, MPH, PhD
Sumati Murli, PhD
Joan Pettit, JD
Wendy Post, MD, MS
Katrina Purtell, RN
Megan Singleton, JD
Kawsar Talaat, MD
Rachel Thronton, MD, PhD
John Toscano, PhD
Ryan Vandrey, PhD
Kala Visvanathan, MD, MHS
Cheryl Dennison Himmelfarb, PhD, MSN, RN